Press Releases June 15, 2026 09:00 AM

Prestige Consumer Healthcare Inc Completes Acquisition of Breathe Right®

Prestige Consumer Healthcare Completes $1.045 Billion Acquisition of Breathe Right® Brand, Expanding Its Consumer Healthcare Portfolio

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
PBH

Prestige Consumer Healthcare Inc. has finalized the acquisition of the iconic Breathe Right® brand and certain other brands from Foundation Consumer Healthcare for $1.045 billion, financed through cash and a new Term Loan B. This acquisition marks Prestige's entry into the nasal strip category and will become the company's largest brand, broadening its portfolio of consumer healthcare products across multiple markets.

Prestige Consumer Healthcare Inc Completes Acquisition of Breathe Right®
PBH
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Prestige acquired the Breathe Right® brand for $1.045 billion, expanding into the nasal strip category.
  • The transaction was financed through available cash and a new Term Loan B.
  • Breathe Right® will become Prestige's largest brand, complementing its existing diverse portfolio of consumer healthcare products sold primarily in the U.S., Canada, and Australia.

TARRYTOWN, N.Y., June 15, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) (“Prestige”) today announced that it has closed the previously announced acquisition of the Breathe Right® brand and certain other brands.

The closing was finalized pursuant to the terms of the asset purchase agreement, announced on March 20, 2026, under which Prestige agreed to acquire the Breathe Right® brand and certain other brands from Foundation Consumer Healthcare for $1.045 billion, or approximately $900 million net of anticipated tax benefits valued at $150 million. Breathe Right®, created in the 1990s, is an iconic #1 brand synonymous with the nasal strip category. It will become the company’s largest brand and represents expansion into a new category for Prestige.

The Company financed the transaction with a combination of available cash on hand and a completed financing of a new Term Loan B.

Further details regarding the transaction and benefits of Prestige are detailed in a presentation dated March 20, 2026 available on the Company’s website at https://ir.prestigebrands.com/.

About Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Breathe Right® nasal strips, Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® and TheraTears® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.


Risks

  • Significant debt financing increases financial leverage and interest obligations, which could impact financial stability.
  • Integration challenges of newly acquired brands could delay realization of anticipated benefits.
  • Market acceptance in the new category (nasal strips) and competition may affect the brand's performance and Prestige's growth projections.

More from Press Releases

Sysco Canada donates $50,000 to Second Harvest to mark 26-year partnership Jun 15, 2026 Roadzen Subsidiary drivebuddyAI Granted Patent for Real-Time Lane Detection System; Demonstrates Technology at InCabin Detroit 2026 Jun 15, 2026 Cycurion Responds to Coordinated Stock Attack While Strengthening Core Business Jun 15, 2026 Paychex Recognized as a Top WorkTech Company by TIME Jun 15, 2026 Edible Garden Issues Letter Encouraging Shareholders to Vote FOR All Proposals at June 17, 2026, Annual Meeting Jun 15, 2026